Brain Stimulation Delivers Comparable Weight Loss in Trials
New clinical evidence suggests noninvasive brain stimulation may achieve weight loss similar to semaglutide in adults with obesity and type 2 diabetes.
A retrospective study published in Obesity reports that repetitive transcranial magnetic stimulation, a noninvasive brain-based therapy, produced 12-month weight loss comparable to semaglutide 0.5 mg weekly and greater than SGLT2 inhibitors in adults with obesity, including those with type 2 diabetes.
Study Details
Obesity treatment has largely focused on…
Keep reading with a 7-day free trial
Subscribe to Just Healthcare to keep reading this post and get 7 days of free access to the full post archives.